P2.14-20 ATORG-003: Dacomitinib With or Without Dose Titration as First-Line Therapy for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
JOURNAL OF THORACIC ONCOLOGY(2019)
关键词
dacomitinib,EGFR mutant NSCLC,Targeted therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络